脐血LAK细胞生物学特性影响因素的研究

采集２３名产妇的脐带血和８名正常成人的外周血制备ＬＡＫ细胞，随机分为４组，在培养第３，５，７，１４天，分别利用ＭＴＴ法和＾１２５Ｉ－ＵｄＲ释放法对４组ＬＡＫ细胞的增殖力和杀伤活性进行了测定，同时用细胞毒方法测定培养７天的ＬＡＫ细胞的免疫表型。结果发现，在不同培养时间，脐血来源的ＬＡＫ细胞增殖力显著高于成人血ＬＡＫ细胞（Ｐ〈０．０５或Ｐ〈０．０１），成人血清组，脐血血清组，红细胞组ＬＡＫ细胞增殖力有     

Hydrops Fetalis Caused by Fetal Kasabach-Merritt Syndrome

There have been only 2 previous reports of nonimmunologic hydrops fetalis (NIHF) caused by fetal Kasabach-Merritt syndrome, both of which were pathological studies. This is the first clinical case report of NIHF due to fetal Kasabach-Merritt syndrome that was prenatally diagnosed by sonography, computerized tomography, and percutaneous umbilical blood sampling.     

脐静脉灌注提高分离人胎肝细胞纯度

应用脐静脉灌注冲洗人胎儿肝脏,胰蛋白酶消化后经光镜及扫描电镜观察,证实可获得纯度为90%以上的肝实质细胞,培养上清液可测出胎甲蛋白活性,证明胎肝细胞具有生物学活性,为应用人肝细胞培养进行生理生化及药理方面的实验研究,提供一种新的获取人肝细胞的方法.     

三种脐疝修补术式的应用探讨

目的 总结脐疝修补术的经验.方法 回顾性分析了我院自2003～2008年期间收治的49例成人脐疝患者手术治疗的临床资料,其中14例行传统脐疝修补术,21例行Kugel补片无张力修补术,14例行疝环填充式无张力修补术,并对3种术式进行分析和总结.结果 14例传统脐疝修补术随访1年后除1例复发,其余均获成功.35例行无张力修补术亦获成功,随访无1例复发.无张力修补术术后疼痛均较轻,但Kugel补片无张力修补术手术时间略长于传统修补术.结论 无张力修补术在治疗成人脐疝中具有安全有效、术后并发症较少,可获得较满意的手术效果.     

单脐动脉与胎儿畸形（附9例分析）

我科自１９８９～１９９２年在２３８例胎盘病检中发现单脐动脉９例，发生率３．７８％。单脐动脉胎儿的特点是畸形率高、死亡率高。本组９例中８例胎儿有各类畸形，畸形率达８８．９％。７例胎儿死亡命死亡率７７．８％。本文就单脐动脉的发生率、形成原因及其与胎儿畸形的关系进行讨论，建议加强妊娠早期保健及围产期检查工作。及早发现单脐动脉胎儿，可为诊断先天性畸形或发现一些隐性畸形提供线索，从而指导临床产科处理，有利于优生优育。     

Absence of a relationship between umbilical cord thickness and coiling patterns.

OBJECTIVE: The purpose of this study was to evaluate a relationship between the umbilical cord thickness and cord coiling patterns during the fetal sonographic anatomic survey in the second trimester of pregnancy. METHODS: This was a prospective study of 470 patients with singleton pregnancies who had a fetal anatomic survey with recorded umbilical coiling patterns between 18 and 23 weeks' gestation. The umbilical cord thickness was assessed as an umbilical diameter at the level of the fetal abdominal cord insertion and compared with the antenatal umbilical coiling index (aUCI), calculated as a reciprocal value of the distance between a pair of umbilical cord coils. RESULTS: Three hundred twenty-one patients had adequate sonographic umbilical cord images and maternal demographic, antenatal, and labor data to meet inclusion criteria. The mean aUCI was 0.41 with 10th and 90th percentiles of 0.21 and 0.60, respectively. A total of 10.6% (34/321) and 9.3% (30/321) of patients were categorized as having hypocoiled and hypercoiled umbilical cords, respectively. The mean cord diameter +/- SD was 9.48 +/- 0.97 mm (range 7.0-12.5 mm). There was no statistically significant correlation between aUCI and umbilical cord thickness (P = .1164). CONCLUSIONS: An aUCI, or umbilical coiling pattern, does not correlate with umbilical cord thickness. It appears that a lesser amount of the umbilical supportive tissue, mainly Wharton jelly, is not related to an increased umbilical cord coiling pattern.     

地塞米松对内毒素作用下人脐静脉内皮细胞表达组织因子、凝血酶调节蛋白和蛋白S的影响

目的观察地塞米松(DEX)对内毒素(LPS)作用于人脐静脉内皮细胞(HUVEC)后表达组织因子(TF)、凝血酶调节蛋白(TM)和蛋白S(PS)的影响.方法24孔板培养的第1～5代HUVEC,在含不同浓度LPS和DEX的无血清培养基中培养一定时间后裂解细胞,应用酶联免疫吸附法(ELISA)测定裂解液中的TF、TM和PS含量.结果在LPS刺激下,HUVEC表达TF的量呈剂量依赖性升高,在LPS0.1μg/ml下TF的表达量为对照组的4倍(P＜0.01),同时加入0.5 μg/ml和1.0 μg/ml DEX则可使TF的表达量由128.3±25.7 pg/105细胞分别降至94.9±19.4 pg/105细胞和98.8±7.8 pg/105细胞(P＜0.05);LPS(0.01～10μg/ml)可抑制HUVEC表达TM,在LPS 10 μg/ml下,TM表达量降至对照组的60%(P＜0.05).DEX可拮抗LPS抑制HUVEC表达TM的效应,0.1 μg/ml、0.5 μg/ml和1.0 μg/ml DEX可使LPS(10 μg/ml)作用下TM的表达量由0.282±0.014 ng/105细胞分别增至0.409±0.009、0.462±0.017和0.362±0.019 ng/105细胞(P＜0.05);LPS(0～10 μg/ml)可抑制HUVEC表达PS,在LPS浓度1.0 μg/ml及10 μg/ml时,PS的表达量分别为对照组的43%和38%(P＜0.01).DEX则拮抗LPS抑制HUVEC表达PS的效应,0.5 μg/ml DEX可使LPS刺激下PS的表达量由13.1±4.8%/2×105细胞增至48.5±10.2%/2×105细胞(P＜0.01).结论LPS促进HUVEC表达TF,抑制HUVEC表达TM和PS.DEX能部分拮抗上述作用,提示DEX可能纠正内毒素血症时的高凝状态.     

不同压力下人脐带静脉的形态变化

运用扫描电镜和光镜观察了人脐带静脉的形态结构及其在0～8.0kPa 压力下的变化.脐静脉结构类似中等动脉.内皮细胞和内弹力膜的形态随实验压力增大而改变.6.7～7.3kPa是脐静脉内膜的临界破坏压,5.3～6.7kPa 是制备脐静脉作为管道移植材料的最佳压力.